Sanofi CEO shrinks his exec committee

The few, the proud, the quick decision-makers. Sanofi-Aventis has set up a small executive committee to set strategy, allocate resources, and oversee company management, according to anonymous sources who talked to APM Europe. The idea is to consolidate decision-making to make management more nimble.

Besides CEO Gerard Le Fur (photo), the committee includes a senior vice chairman who oversees R&D, Marc Cluzel, plus Jean-Claude Leroy, executive vice chair for finance and legal; Gilles Lhernould, senior vice chair for industrial affairs; and Hanspeter Spek, executive vice chair for pharma operations. This small group replaces a larger executive committee.

Next question: How often does this gang of five meet to make its quick decisions?

- read the item at Pharmalot
- read the story from APM Europe

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.